CAMRYN KATE FLANAGAN
Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant JEFFERSON, LA NPI 1295580108
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant LA Kite Pharma, Inc. All categories
General Payments — all program years on this page
$673.37
- Category: General Payments
- Program years: PY2024
- Record count: 8
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $673.37 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $585.38 | 7 |
| Education | $87.99 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Kite Pharma, Inc. | $339.07 | 3 |
| Incyte Corporation | $212.98 | 2 |
| Amgen Inc. | $70.19 | 1 |
| Genmab U.S., Inc. | $31.01 | 1 |
| BeiGene USA, Inc. | $20.12 | 1 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2024 | $673.37 | 8 |
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1115625872 | Amgen Inc. | $70.19 | 09/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1120867098 | BeiGene USA, Inc. | $20.12 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1126834632 | Genmab U.S., Inc. | $31.01 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1128613077 | Kite Pharma, Inc. | $136.10 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1128613079 | Kite Pharma, Inc. | $116.41 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1128613081 | Kite Pharma, Inc. | $86.56 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141232537 | Incyte Corporation | $124.99 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141309143 | Incyte Corporation | $87.99 | 08/15/2024 | Education | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.